Joe Mullings | Sales Leadership DNA Enters Clinical Trials
The very early movers have already started the transition. We will watch a function that […]
The very early movers have already started the transition. We will watch a function that […]
Prepping for LSI in Barcelona this year, with both a headhunter and venture capital mindset, […]
Anne Osdoit, CEO of Moon Surgical, joined me in One60Studios this morning on her way […]
Installment two of a field article series for MedTech companies built outside the United States […]
Artificial Intelligence is not a feature being added to analog devices but more of the […]
Most of the time that distinction does not matter. But in the medtech space, we […]
Fantastic event at Mayo yesterday. A panel in which we discussed in a very animated […]
Early days of surgical robotics, the parochial system in soft tissue surgery was the surgeon. […]
Bill Hunter wrote something recently about CJR-X that most people read as a comment on […]
Great for the category. Steve Bell and I discuss the arrival of Ottava and the […]
The Coming Commoditization Trap: Why Structural Heart Implant Companies Need to Buy Robotic Imaging Before […]
For twenty years we asked the wrong question about surgical robotics. We kept asking which […]
Value provided is not value captured. Great conversation recently at the Mayo Clinic Cardiology & […]
Mission driven, smaller, feature appropriate for site of care and patient, cost and value aligned. […]
Spent time with Thomas Knox in One60Studios recently and we discussed VitVio and the category […]
No matter where you sit in the healthcare system, build for the solution at hand […]
We know going from Zero to One is a challenge in itself. Inertia, flywheel, efforts, […]
Ramping up for Society of Robotic Surgery | SRS 2026 down in our neck of […]
The Mechanical Circulatory Support products are clearly life-saving and life extending. Patrick NJ Schnegelsberg joined […]
It is easy to get caught up in the medtech sexy stuff. The robots. The catheters. The heart […]
Every technology rush creates its own shadow market. When the masses go all in on […]
In just the past few years, the Digitally Guided Surgery and Robotic Assisted Surgery has […]
Jannis Fischer, one of the Founders as well as CEO with Positrigo joined me in […]
Navigating and persevering to”pulling up the gap” We all need to get a grip on […]
I had the opportunity to chat with Michael Shriver, MD about the Positrigo NeuroLF platform […]
When a category transitions from mechanical precision to digital intelligence, the incumbent tool companies eventually […]
The surgical robotics market is undergoing a structural correction that makes it difficult to name […]
Here comes one of the early waves of market shift in orthopedics. THINK Surgical adding […]
When there has been a therapeutic technology in place for more than a decade and […]
Device innovators. Adoption and ongoing utilization. The conversation taking place in the current societal workforce […]
How do I transition over to Private Equity (PE) from a career in medtech at […]
How do Johnson & Johnson and Medtronic have a chance at competing and perhaps even […]
Kill the monster when it is tiny. The earlier a potential threat is identified and […]
Diligent Robotics gets acquired. Good timing for a conversation I had for My Year in […]
Ottava and Hugo ramping up. While most of the conversation around the Big Three soft […]
We are seeing the early stages of leadership and organizational structure changes in the large […]
Hugo FDA cleared. Another entrant in the U.S. market. The clarity and market stratification will […]
Being Bold is not for everyone.In fact, it intimidates most. Ivan Tornos joined me at […]
Highly featured, highly priced, and highly catering to the upper percentile of patients across the […]